PMDA adds March 2026 data to suspected-malfunction case reports (regenerative medicine products)
「不具合が疑われる症例報告に関する情報（再生医療等製品）」に2026年3月分の情報を追加しました
Published: 2026-07-22 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) announced that it has added information for March 2026 to its page on case reports of suspected malfunctions (defects) involving regenerative medicine products. This is a government information update on a safety-information webpage, published 2026-07-22. The metadata does not describe the content of the added reports.
Business Impact
Companies handling regenerative medicine products may find the added case information relevant to their own safety monitoring or post-marketing activities. The practical significance for any specific product cannot be determined from the metadata provided.
Recommended Action
Review the official PMDA page (https://www.pmda.go.jp/safety/info-services/ctp/0006.html) in Japanese to determine whether the added March 2026 information is relevant to your products.